Trailing-twelve-month (TTM) revenue is $54.09 Million with a year-over-year growth of +22.56%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $12,807,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $13,015,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-04 |
| Q1 FY2026Period ended 2026-03-31 | $14,446,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13 |
| Q2 FY2026Period ended 2026-06-30 | $13,819,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $54,087,000 |
Current P/S: $572,756,855 market capitalization ÷ $54,087,000 TTM revenue = 10.59x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:50:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $13.82M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:50:33.819Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Co-Development and Research Fees | $1M | $2M | $1M | $1M | $2M | $1M |
| License and Royalty Revenue | $14M | $5M | $2M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $5M | $8M | $8M | $13M | $18M | $15M |
| United States | $41M | N/A | N/A |
$54.09M
$54.09 Million
+22.56%
vs. $44.13M a year ago (TTM)
(0.58%)
5 Year compound annual growth rate
1 Year
+22.56%
3 Year
+5.15%
5 Year
(0.58%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $44.55M | ($13.02M) | (22.61%) |
| 2024 | $57.56M | +$6.98M | +13.80% |
| 2023 | $50.58M | +$2.90M | +6.09% |
| 2022 | $47.68M | ($3.15M) | (6.20%) |
| 2021 | $50.83M | +$4.98M | +10.87% |
| 2020 |
TTM Growth
+22.56%
3-Year CAGR
+5.15%
5-Year CAGR
(0.58%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T17:50:33.819Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $15M |
| $4M |
| Manufacture and Supply Revenue | $25M | $35M | $36M | $44M | $40M | $40M |
|---|
| Proprietary Product Sales | $6M | $9M | $8M | $0 | N/A | N/A |
|---|
| Royalty | N/A | -$1M | N/A | N/A | N/A | N/A |
|---|
| N/A |
| N/A |
| UNITED STATES | N/A | $43M | $40M | $37M | $40M | $30M |
|---|
| $45.85M |
| ($6.76M) |
| (12.85%) |
| 2019 | $52.61M | ($14.82M) | (21.98%) |
| 2018 | $67.43M | +$512,000 | +0.77% |
| 2017 | $66.92M | +$15.13M | +29.22% |
